This analysis reflects carrier participation, pricing, and plan type trends for the 2018 individual exchange open enrollment period. Findings are across 50 states and D.C.
Why consumers are crucial for building a sustainable healthcare systemMcKinsey on Healthcare
McKinsey & Company hosted an event in Washington, DC on March 26 in partnership with the Duke-Margolis Center for Health Policy, “Why consumers are crucial for building a sustainable healthcare system.”
Insights into the 2020 Medicare Advantage marketKim Simoniello
McKinsey’s Center for US Health System Reform recently completed independent research on the options available to consumers selecting Medicare Advantage plans this fall, based on public use data files from the Centers for Medicare & Medicaid Services (CMS).
Insights into the 2020 individual marketplace—increase consumer choice and de...Kim Simoniello
This analysis reflects carrier participation, pricing, and plan type trends for the 2020 individual exchange open enrollment period. Findings are across 50 states and DC.
In July 2021 (July 16–24), McKinsey surveyed strategic and operational leaders from 100 large private sector hospitals in the country to see how COVID-19 had impacted hospital volumes, and to understand what expectations and implications were for the upcoming year(s). A similar survey was also conducted in May 2021, February 2021, and July 2020, with ~30 large health system respondents.
Some hospitals have reported returning to pre-COVID-19 volumes for certain services, but the pandemic continues to affect outpatient and surgical volumes, largely due to workforce capacity constraints.
2017 hospital networks: perspectives from four years of the individual exchangesMcKinsey on Healthcare
An analysis of the indivdual market health plans being offered across the U.S.reveals that the trends toward narrowed hospital networks and managed care continue.
Why consumers are crucial for building a sustainable healthcare systemMcKinsey on Healthcare
McKinsey & Company hosted an event in Washington, DC on March 26 in partnership with the Duke-Margolis Center for Health Policy, “Why consumers are crucial for building a sustainable healthcare system.”
Insights into the 2020 Medicare Advantage marketKim Simoniello
McKinsey’s Center for US Health System Reform recently completed independent research on the options available to consumers selecting Medicare Advantage plans this fall, based on public use data files from the Centers for Medicare & Medicaid Services (CMS).
Insights into the 2020 individual marketplace—increase consumer choice and de...Kim Simoniello
This analysis reflects carrier participation, pricing, and plan type trends for the 2020 individual exchange open enrollment period. Findings are across 50 states and DC.
In July 2021 (July 16–24), McKinsey surveyed strategic and operational leaders from 100 large private sector hospitals in the country to see how COVID-19 had impacted hospital volumes, and to understand what expectations and implications were for the upcoming year(s). A similar survey was also conducted in May 2021, February 2021, and July 2020, with ~30 large health system respondents.
Some hospitals have reported returning to pre-COVID-19 volumes for certain services, but the pandemic continues to affect outpatient and surgical volumes, largely due to workforce capacity constraints.
2017 hospital networks: perspectives from four years of the individual exchangesMcKinsey on Healthcare
An analysis of the indivdual market health plans being offered across the U.S.reveals that the trends toward narrowed hospital networks and managed care continue.
As the Affordable Care Act (ACA) third individual-market open enrollment period (OEP) came to a close in January, McKinsey’s Center for U.S. Health System Reform conducted its eighth national online survey to gather insights into how the individual-market and consumer behavior have evolved.
Consumers’ top reasons for delaying healthcare visits in the UAE include concerns around exposure to other people coupled with a lack of trust in facility safety.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
The Power and Promise of Unstructured Patient DataHealthline
Unstructured search capabilities, superior natural language processing, and healthcare ontology capabilities will help distinguish the leading products information and data-driven decision making.
Medical Costs 2021- Analyst Insights from PwC Health Research InsittuteLevi Shapiro
Presentation for mHealth Israel covering medical cost trends in the midst of the COVID-19 pandemic. Presenters are Ben Isgur, Health Research Institute Leader, and Ingrid Stiver, Senior Manager, Health Research Institute. Medical cost trends could range from 4% to 10% in 2021. Employer healthcare spending could fall in calendar year 2020 compared with 2019, and then rebound in 2021. Individuals with complex chronic conditions on employer-sponsored insurance were more likely to have delayed care. As a trusted source, providers have an opportunity to better communicate with their patients during the pandemic. During the Great Recession, unemployment increased by 8 million and employer-sponsored health insurance dropped by over 11 million. Breakdown of Inflators and Deflators affecting 2021 medical cost trends. COVID-19 boosts mental health utilization. Individuals with complex chronic disease and mental illness cost employers 12x more than healthy ones. Most medications in the pipeline are specialty drugs. Expanding indications for approved specialty drugs increase spending. Telehealth goes mainstream. Most commercial insurers are temporarily waiving cost sharing on telehealth visits during the COVID-19 pandemic. Networks narrow out of necessity. 35% of individuals with employer-sponsored insurance would choose a narrow network to avoid a premium increase. Includes LOW, MEDIUM and HIGH cost growth trend scenarios.
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
The Science of Launching and Achieving Growth in Oncologyaccenture
We have conducted research to understand how oncology companies are responding to New science, more treatment choices and changing economics. Visit https://accntu.re/2Jn72wq to learn our key takeaways for launching and achieving growth in oncology.
mHealth Israel_Impact of Digital Innovations on Healthcare in Asia: 2020_Finn...Levi Shapiro
Report by Finn Partners: Impact of Digital Innovations on Healthcare in Asia- 2020. Deep-dive analysis across healthcare delivery, healthcare financing and healthcare discovery. Sections include Healthcare in the Digital Age, Digital health brings patient care to where it is needed the most, Innovative fintech solutions deliver affordable healthcare to Asia, More data and better insights delivered by AI and machine learning, Digital health is the future.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
Insights into the 2018 individual exchange marketKim Simoniello
This analysis reflects carrier participation, pricing, and plan type trends for the 2018 individual exchange open enrollment period. Findings are across 50 states and D.C.
As the Affordable Care Act (ACA) third individual-market open enrollment period (OEP) came to a close in January, McKinsey’s Center for U.S. Health System Reform conducted its eighth national online survey to gather insights into how the individual-market and consumer behavior have evolved.
Consumers’ top reasons for delaying healthcare visits in the UAE include concerns around exposure to other people coupled with a lack of trust in facility safety.
A new report from PwC’s Health Research Institute predicts that insurance companies will be spending more to pay for prescription drugs starting next year, from around 3% to almost 6% by 2027. Here’s more forecasts on medical spending from the report:
•Generics: Almost half of the estimated sales from the top 100 brand-name drugs won’t be affected by generic competition for another three years.
•Specialty drugs: Spending on specialty drugs — such as biologics or rare disease treatments — has already been growing over the past five years, but by 2020 these drugs may make up more than half of all U.S. drug spending.
•Chronic disease: 85% of all employer-provided insurance spending is on chronic conditions, and obesity and diabetes will be the two top conditions that will account for spending in 2020.
The Power and Promise of Unstructured Patient DataHealthline
Unstructured search capabilities, superior natural language processing, and healthcare ontology capabilities will help distinguish the leading products information and data-driven decision making.
Medical Costs 2021- Analyst Insights from PwC Health Research InsittuteLevi Shapiro
Presentation for mHealth Israel covering medical cost trends in the midst of the COVID-19 pandemic. Presenters are Ben Isgur, Health Research Institute Leader, and Ingrid Stiver, Senior Manager, Health Research Institute. Medical cost trends could range from 4% to 10% in 2021. Employer healthcare spending could fall in calendar year 2020 compared with 2019, and then rebound in 2021. Individuals with complex chronic conditions on employer-sponsored insurance were more likely to have delayed care. As a trusted source, providers have an opportunity to better communicate with their patients during the pandemic. During the Great Recession, unemployment increased by 8 million and employer-sponsored health insurance dropped by over 11 million. Breakdown of Inflators and Deflators affecting 2021 medical cost trends. COVID-19 boosts mental health utilization. Individuals with complex chronic disease and mental illness cost employers 12x more than healthy ones. Most medications in the pipeline are specialty drugs. Expanding indications for approved specialty drugs increase spending. Telehealth goes mainstream. Most commercial insurers are temporarily waiving cost sharing on telehealth visits during the COVID-19 pandemic. Networks narrow out of necessity. 35% of individuals with employer-sponsored insurance would choose a narrow network to avoid a premium increase. Includes LOW, MEDIUM and HIGH cost growth trend scenarios.
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
The Science of Launching and Achieving Growth in Oncologyaccenture
We have conducted research to understand how oncology companies are responding to New science, more treatment choices and changing economics. Visit https://accntu.re/2Jn72wq to learn our key takeaways for launching and achieving growth in oncology.
mHealth Israel_Impact of Digital Innovations on Healthcare in Asia: 2020_Finn...Levi Shapiro
Report by Finn Partners: Impact of Digital Innovations on Healthcare in Asia- 2020. Deep-dive analysis across healthcare delivery, healthcare financing and healthcare discovery. Sections include Healthcare in the Digital Age, Digital health brings patient care to where it is needed the most, Innovative fintech solutions deliver affordable healthcare to Asia, More data and better insights delivered by AI and machine learning, Digital health is the future.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
Insights into the 2018 individual exchange marketKim Simoniello
This analysis reflects carrier participation, pricing, and plan type trends for the 2018 individual exchange open enrollment period. Findings are across 50 states and D.C.
Snapshot report - Sustainability in TruckingJennifer Wong
In August 2020 Convoy surveyed over 440 small and mid-sized trucking companies across the United States to collect a snapshot of sustainability in trucking. Survey participants include dispatchers for fleets and owner-operators. All the results are self reported by the participants. This report is data from over 31,787,562 miles driven in July.
You can watch this webinar at: http://www.screencast.com/t/QqEn0CyB
Dr. David Knott and Erica Hutchins Coe from McKinsey & Company examined both current market participants and new entrants including Medicaid health plans, co-ops, and provider sponsored health plans using a database of rate filings for 21,000 plans across 50 states and Washington, DC. View a recording of their presentation to understand where competitors are playing, who is selling what kinds of products and networks, and who is most competitively priced to win.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
Electric vehicles and electric utilities – a clear opportunity with many shapesCarlo Stella
While several stakeholders are supportive of the widespread adoption of electric vehicles, we have looked specifically at electric utilities to understand the opportunities that such a change in the transportation landscape can generate, and define the key questions to be addressed in order to embrace them. We have identified four business models – by no means evolutionary – that can be looked at independently, and eventually combined to fit the company’s strategy and the specific market conditions (e.g., regulation, competition, ecosystem, customer readiness). We strongly believe electric utilities are ideally positioned to leverage the opportunities offered by the adoption of electric vehicles on a mass-market scale, but they need to act fast, as many other players are addressing the same opportunity
Modeling State-based Reinsurance: One Option for Stabilization of the Individ...soder145
Presentation by SHADAC Director Lynn Blewett at the 2018 Association for Public Policy Analysis and Management (APPAM) Fall Research Conference in Washington, DC.
Moreover, demand for industrial rubber such as in conveyor belts and hoses is anticipated to positively influence Carbon Black demand in India during forecast period 2022-2030. Carbon Black is a crude oil derivative and hence its price is directly linked to the fluctuations in crude oil prices internationally. Volatility in the prices of crude oil has remained a major challenge for Carbon Black manufacturers in 2020.
This publication has been developed in collaboration between Strategy&, PwC's global strategy consulting business, alongside PwC industry and function experts. Together, we transform organizations by developing actionable strategies that deliver results.
Mercer Capital's Value Focus: Insurance Industry | Q3 2015Mercer Capital
Mercer Capital’s Insurance Industry newsletter is a quarterly publication providing perspective on valuation issues pertinent to insurance brokers, underwriters, and other industry professionals. Each issue includes a segment focus, market overview, mergers and acquisitions review, and more.
I made this assignment for a Strategy Module (University of Westminster) this year and I thought it looked nice. It is important to point out I don't work and have never worked for PWC, it was just a requirement of the assignment to pretend you worked there.
American consumers are navigating a “new normal” of living with COVID-19, embracing at-home testing and the added convenience of virtual care, and seeking new options for how and where they conduct work, according to the latest consumer healthcare insights survey.
These insights draw upon findings from McKinsey’s Consumer Surveys from March 15–22, February 8–12, January 4–11, 2021, and in 2020, November 20, December 6, October 22–26, September 5–7, July 11–14, June 4–8, May 15–18, April 25–27, April 11–13, March 27–29, and March 16–17, 2020 on COVID 19.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Insight into the 2018 individual exchange market - PPT
1. Insights into the
2018 individual exchange market
November 30, 2017
CONFIDENTIAL AND PROPRIETARY
Any use of this material without specific permission of McKinsey & Company is strictly prohibited
2. 2McKinsey & Company
Insights into the 2018 individual exchange market
• Although there are fewer carriers in 2018 than 2017 (194
vs. 234), there are 8 new carriers/market entries in 2018.
• All consumers1 will have access to at least 1 carrier in
2018. 26% of consumers will have access to 1 carrier,
and 74% will have a choice of two or more carriers.
Corresponding figures in the 2017 exchange market
were 19% and 81%, respectively.
• Most carrier types filed to offer plans to a smaller share of
consumers in 2018 than in 2017. National carriers filed to
offer plans to 10% of consumers in 2018, compared with
26% in 2017, and Blues carriers filed to offer plans to
79% of consumers, compared with 93% in 2017.
• Among consumers with 1 carrier option in 2018, 37%
will have at least 10 plans to choose from across
bronze, silver, gold, and platinum metal tiers. Plan
options increase as carrier choice increases.
• HMOs make up 49% of plans that are within 10% of
the lowest-price plan in a given county in 2018,
compared with 52% in 2017. Also, the median 2017 to
2018 change in the lowest-price silver plan premium is
higher among HMO and EPO plans (34%) than PPO
and POS plans (27%).
1 3
1 Defined as the population eligible to purchase a qualified health plan
(QHP).
2 On October 12, 2017, the Trump administration announced that it would
not make cost-sharing reduction (CSR) payments to carriers. Most
states instructed carriers to account for the loss of CSR funding in the
2018 plan year. However, the approaches vary -- for example, many
states required carriers to load additional premium increases onto silver
tier plans, while others asked insurers to spread additional premium
increases across all metal tiers. Thus, there is variation in premium
trends across states and metal tiers.
• The median gross premium (before subsidies) of the
lowest-price silver plan will increase by 31% from 2017
to 2018, compared with 25% from 2016 to 2017. Prices
in all other metal tiers will increase by a range of 12% to
18% from 2017 to 2018. Some premiums may have
been affected by the regulatory decision to end cost-
sharing reductions (CSRs).2
• A majority (62%) of subsidy-eligible consumers may see
the net premium of the lowest-price silver plan in their
county decline in 2018, compared with 48% in 2017.
• Among subsidy-eligible consumers, access to a plan
with a net monthly premium of either $10 or less – or
$75 or less – increased from 2017 to 2018 across
bronze, silver, and gold metal tiers. 50% and 70% of
subsidy-eligible consumers have access to bronze plan
with a net monthly premium of $10 or less or $75 or less,
respectively.
2Carrier participation Pricing Plan options
Note: This analysis reflects carrier participation, pricing, and plan type trends for the
2018 individual exchange open enrollment period. Findings are across 50 states and
D.C.
3. 3McKinsey & Company
Although there are fewer carriers in 2018 than 2017, there are 8
new carriers/market entries in 2018
Carrier participation
Number of on-exchange carriers, counting at a carrier and state level
1
New EntrantsIncumbents Withdrawals
307
100
75
75
19
70
70
49
31
31
90
49
207
263
284
224
186
2016
new
entrant
s
2015
carriers
333
2015
new
entrant
s
10
2013
pre-
reform
No
exchange
entry
2014
carriers
282
2015
withdrawals
8
2018
withdrawal
s
2018
new
entrant
s
315
10
2017
carrier
s
8
2018
carrier
s
194
234
2017
new
entrants
2017
withdrawals
2016
carriers
2016
withdrawals
New
Entrants
SOURCE: McKinsey Exchange Offering Database
Note: Carrier's participation status in a given year and state is defined as follows: Incumbent: A carrier that offered exchange plans during the prior year. For 2014 only, these are carriers that had individual market
experience in 2013 in that given state. Withdrawal: A carrier that stopped participating on-exchange. For 2013 to 2014 withdrawals, these are carriers with individual experience in a given state that did not enter
exchanges in 2014. New entrant: A carrier that did not participate on-exchange in the prior year but is joining exchanges for a given year and state. For 2014, these are carriers without individual experience in that
state during 2013.
4. 4McKinsey & Company
Carrier participation by county varies widely; 10 states will
have 1 carrier in each county in 2018
Carrier participation
Number of carriers by county1,2
1
3-4 carriers1 carrier 5+ carriers2 carriers
1 Counting carriers that offer at least 1 silver plan at a parent company level.
2 States with one carrier remaining in each county are Alaska, Arizona, Delaware, Iowa, Kentucky, Mississippi, Nebraska, Oklahoma, South Carolina, and
Wyoming. However, these states may have more than 1 carrier total participating in the state.
SOURCE: McKinsey Center for US Health System Reform
2014 2015
2016 2017
2018
5. 5McKinsey & Company
A majority of consumers continue to have carrier choice, though the
percentage with access to fewer carriers has increased
SOURCE: McKinsey Center for US Health System Reform, McKinsey MPACT Model
1 Defined as the population eligible to purchase a qualified health plan (QHP).
2 Counting carriers that offer at least 1 silver plan at a parent company level.
consumer choice of carriers
% of consumers1 seeing a given number of carriers in their county2
1
3-4 carriers1 carrier 5+ carriers2 carriers
2014 20162015 2017
34%
57%
51%
22%
15%
42%
32%
34%
37%
34%
0
0
0
0
0
7%
2% 2%
19%
26%
2018
18%
8%
2%
13%
22%
25%
2%
6. 6McKinsey & Company
Most carrier types filed to offer plans to a smaller share of exchange
consumers in 2018 than in 2017
SOURCE: McKinsey Center for US Health System Reform, McKinsey MPACT model
1 Blues: a Blue Cross Blue Shield payor (e.g., Anthem, HCSC); Consumer-operated-and-oriented plan (CO-OP): a recipient of federal CO-OP grant funding that was not a commercial payor before 2014 ; Medicaid: a carrier that
offered only Medicaid insurance in the past, includes Molina and Centene, along with regional/local Medicaid carriers ; National: a commercial payor with a presence on exchanges (e.g., Aetna, Cigna, UnitedHealthcare,
Humana); Provider: a carrier that also operates as a provider/health system ; Regional/local: a commercial payor with a presence in four or fewer states (most often, just one state) that has filed on the exchanges.
2 Defined as the population eligible to purchase a qualified health plan (QHP).
Exchange participation by carrier type1
% of consumers2 with access to a plan (on any metal tier) of a given carrier type in their county
20172015 20182016
98
55
33
37
52
31
98
59
37 39
71
35
96
60
40 42
75
17
93
48
45
36
26
5
79
46
51
31
10
3
Regional/local CO-OPMedicaidProviderBlue National
2014
1
7. 7McKinsey & Company
Silver plan gross premiums (before subsidies) from 2017 to 2018 increased more than
from 2016 to 2017, but increases on all other metal tiers are smaller
SOURCE: McKinsey Center for US Health System Reform
Gross premium change by metal tier
Median % change in gross premium1 (before subsidies) of the lowest-price plan,
calculated at a county level
31%
25%
13%
4%
Silver
18%
27%
15%
7%
Bronze
12%
32%
15%
5%
Gold
18%
22%
23%
11%
Platinum
12%
24%
11%
9%
Catastrophic
2016-20172014-2015 2017-20182015-2016
2
1 On October 12, 2017, the Trump administration announced that it would not make cost-sharing reduction (CSR) payments to carriers. Most states instructed carriers to account for
the loss of CSR funding in the 2018 plan year. However, the approaches vary -- for example, many states required carriers to load additional premium increases onto silver tier
plans, while others asked insurers to spread additional premium increases across all metal tiers. Thus, there is variation in premium trends across states and metal tiers.
8. 8McKinsey & Company
A majority of subsidy-eligible consumers may see the net
premium of the lowest-price silver plan in their county decline in
2018
SOURCE: McKinsey Center for US Health System Reform, McKinsey MPACT Model
1 This includes only subsidy-eligible consumers (those
with incomes below 400% of the federal poverty
level), among consumers defined as eligible to
purchase a qualified health plan (QHP). In cases
where states change their eligibility requirements
(e.g., via Medicaid expansion) we use the most
recent set of eligibility determinations for all years
(such that we are always comparing what a
consistent population would observe).
2 On October 12, 2017, the Trump administration
announced that it would not make cost-sharing
reduction (CSR) payments to carriers. Most states
instructed carriers to account for the loss of CSR
funding in the 2018 plan year. However, the
approaches vary -- for example, many states
required carriers to load additional premium
increases onto silver tier plans, while others asked
insurers to spread additional premium increases
across all metal tiers. Thus, there is variation in
premium trends across states and metal tiers.
Change in silver net premium for subsidy-eligible consumers
% of subsidy-eligible1 consumers seeing a change in the net premium2 (after subsidies) of the lowest-
price silver plan in their county
31%
24%
18% 14%
41%
39%
33%
22%
1
1
1
2
18%
24%
29%
33%
9% 12%
19%
29%
2014-2015 2016-
2017
2015-
2016
2017-2018
Over 10% decrease
Within 10% decrease
No change
Within 10% increase
Over 10% increase
1%
2
2
1%
1%
2%
9. 9McKinsey & Company
Subsidy-eligible consumers may see a decline in net premium
when selecting the lowest-price plan
SOURCE: McKinsey Exchange Offering Database
1 On October 12, 2017, the Trump administration announced that it would not make cost-sharing reduction (CSR) payments to carriers. Most states instructed carriers to account for the loss of CSR funding in the
2018 plan year. However, the approaches vary -- for example, many states required carriers to load additional premium increases onto silver tier plans, while others asked insurers to spread additional premium
increases across all metal tiers. Thus, there is variation in premium trends across states and metal tiers.
2 This includes only subsidy-eligible consumers (those with incomes below 400% of the federal poverty level), among consumers defined as eligible to purchase a qualified health plan (QHP). In cases where states
change their eligibility requirements (e.g., via Medicaid expansion) we use the most recent set of eligibility determinations for all years (such that we are always comparing what a consistent population would
observe).
Change in net premium by metal tier and income 2017 to 2018
Weighted average change ($) in net premium (after subsidies) of the lowest-price plan1 by metal tier
and percentage of federal poverty level (FPL) for subsidy-eligible consumers2, calculated at a county
level
-$2
-$10
-$8
Silver
-$50
-$47
-$21
Bronze
-$26
-$38
-$43
Gold
150-200% FPL
300-400% FPL
200-300% FPL
2
Income
150-200% FPL
200-300% FPL 300-400% FPL
-$2
10. 10McKinsey & Company
Access to a plan with a net monthly premium of either $10 or less – or $75 or
less –
increased from 2017 to 2018
SOURCE: McKinsey Exchange Offering Database, McKinsey MPACT model
Consumers with access to a plan with a net monthly premium (after subsidies) of $10 and $75
or less2,3
% of subsidy-eligible1 consumers by metal tier
2
1 This includes only subsidy-eligible consumers (those with
incomes below 400% of the federal poverty level), among
consumers defined as eligible to purchase a qualified
health plan (QHP). In cases where states change their
eligibility requirements (e.g., via Medicaid expansion) we
use the most recent set of eligibility determinations for all
years (such that we are always comparing what a
consistent population would observe).
2 $10 and $75 benchmarks are illustrative of potential
reductions in net premium as a result of advanced
premium tax credits and consumers selecting the lowest
price option in a given metal tier.
3 On October 12, 2017, the Trump administration announced
that it would not make cost-sharing reduction (CSR)
payments to carriers. Most states instructed carriers to
account for the loss of CSR funding in the 2018 plan year.
However, the approaches vary -- for example, many states
required carriers to load additional premium increases onto
silver tier plans, while others asked insurers to spread
additional premium increases across all metal tiers. Thus,
there is variation in premium trends across states and
metal tiers.
2017 2018
Net monthly premium of $75 or less
49%
24%
1%
70%
29%
13%
Bronze Silver Gold
Net monthly premium of $10 or less
25%
5%
0%
50%
9%
3%
Bronze Silver Gold
11. 11McKinsey & Company
Consumers’ access to plan options increases as access to carriers
increases
SOURCE: McKinsey Exchange Offering Database, McKinsey MPACT model
Breakdown of consumers (%) by access to
number of carriers in their county, 2018
% of consumers1, number of carriers2
20 to 30Less than 10 30 to 4010 to 20
2018 2018
1 Defined as the population eligible to purchase a qualified health plan (QHP).
2 Counting carriers at a parent company level.
3 Includes bronze, silver, gold, and platinum metal tiers.
Breakdown of consumers1 (%) by access to number of products
within each number of carriers2 category, 2018
% of consumers1, number of products3, number of carriers2
2
5+
3 to 4
1
40+
15%
34%
26%
25
%
3
0%
2%
63%
0%
7%
51%
26%
53%
35%
20%
4% 8%2
1
3 to 4
5+
9%
83%17%
20%
2%
0%
2%
12. 12McKinsey & Company
HMO and EPO plans continue to have increase in
proportion, but PPO and POS plans decline
SOURCE: McKinsey Center for US Health System Reform
POSPPO
Plan type distribution
% of plan offerings1, calculated at the county level
9% 9% 9% 8% 8%
47%
36%
29% 28%
23%
8%
8%
13%
12% 20%
36%
47% 49% 52% 49%
Plans within 10% of lowest-price plan (gross
premium)
2014 20162015 2017
All plans
EPOHMO
2018
8% 7% 9% 8% 8%
50% 49%
36%
28% 24%
9%
8%
12%
12% 19%
33% 36%
43%
52% 49%
2014 20162015 2017 2018
3
1 Does not include catastrophic plans.
13. 13McKinsey & Company
Consumers continue to have fewer lower-priced PPO and POS options
SOURCE: McKinsey Center for US Health System Reform, McKinsey MPACT model
1 Defined as the population eligible to purchase a qualified health plan (QHP).
2 Does not include catastrophic plans.
3 Defined as at least 1 PPO or POS plan and at least 1 HMO or EPO plan.
HMO, EPO only
Consumer access to plan types
% of consumer1 access to plan types2 across all metal tiers, calculated at a county level
20%
11% 7%
13% 14%
41%
53%
42%
18% 14%
39% 36%
51%
69% 72%
2014 20162015 2017
All plans
Both plan categories3 PPO, POS only
2018
12% 8% 5%
12% 13%
80% 87%
75%
48%
34%
8% 5%
20%
40%
53%
2014 20162015 2017 2018
3
Plans within 10% of lowest-price plan (gross
premium)
14. 14McKinsey & Company
8%
16%
28% 27%
2
9%
19%
34%
From 2017 to 2018, the percentage premium increases for PPO and POS
plans did not exceed those of HMO and EPO plans
SOURCE: McKinsey Center for US Health System Reform
Premium change by plan type
Median % increase in the lowest-price silver gross premium1 (before subsidies) by plan
type, calculated at a county level
Premium change in HMO/EPO
plans
Premium change in PPO/POS plans
2016-20172014-2015 2017-20182015-2016
3
2%
1 On October 12, 2017, the Trump administration announced that it would not make cost-sharing reduction (CSR) payments to carriers. Most states instructed carriers to account for
the loss of CSR funding in the 2018 plan year. However, the approaches vary -- for example, many states required carriers to load additional premium increases onto silver tier
plans, while others asked insurers to spread additional premium increases across all metal tiers. Thus, there is variation in premium trends across states and metal tiers.
15. 15McKinsey & Company
Over time, most carrier types have increased the proportion of their
offerings that are HMO or EPO plans
SOURCE: McKinsey Center for US Health System Reform
1 Blues: a Blue Cross Blue Shield payor (e.g., Anthem, HCSC); Consumer-operated-and-oriented plan (CO-OP): a recipient of federal CO-OP grant funding that was not a commercial payor before 2014 ; Medicaid:
a carrier that offered only Medicaid insurance in the past, includes Molina and Centene, along with regional/local Medicaid carriers ; National: a commercial payor with a presence on exchanges (e.g., Aetna,
Cigna, UnitedHealthcare, Humana); Provider: a carrier that also operates as a provider/health system ; Regional/local: a commercial payor with a presence in four or fewer states (most often, just one state) that
has filed on the exchanges.
2 Does not include catastrophic plans.
Plan type distribution by carrier type1
% of plan offerings that are HMO or EPO plans2
20172015 20182016
34
84
23
62
55
33
30
81
41
59 59
34
42
91
71 69
47
22
58
92
60
70
60
31
62
92
99
69
62
29
Regional/local CO-OPMedicaid ProviderBlue National
2014
3
16. 16McKinsey & Company
Methodology
Overarching methodology: Findings in this document are based on publicly available
information. 2014 through 2018 rates come from the McKinsey Exchange Offering
Database, which includes county and plan level information from publicly available rate
filings and healthcare.gov. The qualified health plan (QHP)-eligible population is
estimated using McKinsey’s MPACT model, based on public sources (e.g., US Census,
American Community Survey), defined as individual market-eligible/enrolled or
uninsured, and eligible for Medicaid but uninsured.
Pricing1: 2014 through 2017 pricing information is based on publicly available approved
rates, and 2018 information is based on healthcare.gov as well as state-based
exchanges. All analyses are at the county level. This report does not include off-
exchange pricing data. To understand the net premium changes that subsidy-eligible
individuals will face, we calculated the weighted average change in net premiums
between 2017 and 2018 for the lowest-price silver plan in each rating area. First, we
established a distribution of subsidy-eligible individuals (at a household level) in each
rating area, using McKinsey’s MPACT model (based on public sources: Census Bureau,
ACS, SAHIE). Next, we combined this population distribution with data about 2017 and
2018 lowest-price silver plan net premiums, calculating per-member-per-year net
premiums at a household level. To estimate net premiums, we used income level and
household size to determine the relative maximum premium (premium cap) for each
household unit. Then, we calculated the second lowest-price silver premium based on
the median age for each age bucket combined with household size to determine the
relative subsidy, and applied that to the lowest-price silver plan to calculate the net
premium of the lowest-price silver plan. Finally, we used the 2017 and 2018 net
premiums to calculate weighted-average rate changes for 50 states and D.C.
individually and collectively.
Carrier participation: To calculate the counts of carrier participation, we analyzed the
number of unique carrier names that are offering plans on-exchange. In the case where
a single parent company offers plans under multiple carrier names, we count each
carrier
separately. To calculate the consumer view of carrier participation, we analyzed the
number of unique parent companies that are offering plans on-exchange, to be reflective
of what a consumer perceives.
Plan types: Plan types reported here were taken directly from carrier rate filings and
Summary of Benefits and Coverage (SBC) documents. Independent assessment of plan
types was not part of the analysis presented in this document. Plan types are defined as
follows:
HMO: a health maintenance organization is a plan typically centered around a
primary care physician who acts as gatekeeper to other services and referrals; it
usually provides no coverage for out-of-network services, except in emergency or
urgent care situations
EPO: an exclusive provider organization is a plan similar to an HMO. It usually
provides no coverage for any services delivered by out-of-network providers or
facilities except in emergency or urgent-care situations; however, it generally does
not require members to use a primary care physician for in-network referrals
PPO: a preferred provider organization is a plan that typically allows members to see
physicians and get services that are not part of a network, but out-of-network services
often require a higher copayment
POS (unmanaged plan): a point-of-service plan is hybrid of an HMO and a PPO; it is
an open-access model that may assign members to a primary care physician and
usually provides partial coverage for out-of-network services
1 On October 12, 2017, the Trump administration announced that it would not make cost-sharing reduction (CSR) payments to carriers. Most states instructed carriers to account for
the loss of CSR funding in the 2018 plan year. However, the approaches vary -- for example, many states required carriers to load additional premium increases onto silver tier
plans, while others asked insurers to spread additional premium increases across all metal tiers. Thus, there is variation in premium trends across states and metal tiers.